IVD Medical Holding Limited
HKEX:1931.HK
1.8 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,088.387 | 2,748.809 | 2,730.67 | 2,428.21 | 2,332.74 | 413.635 | 338.268 | 290.441 |
| Cost of Revenue
| 2,416.686 | 2,140.668 | 2,164.402 | 1,952.045 | 1,829.542 | 296.964 | 230.054 | 206.543 |
| Gross Profit
| 671.701 | 608.141 | 566.268 | 476.165 | 503.198 | 116.671 | 108.214 | 83.898 |
| Gross Profit Ratio
| 0.217 | 0.221 | 0.207 | 0.196 | 0.216 | 0.282 | 0.32 | 0.289 |
| Reseach & Development Expenses
| 8.665 | 7.219 | 7.274 | 3.516 | 2.74 | 0.716 | 0.597 | 0.117 |
| General & Administrative Expenses
| 159.98 | 152.917 | 183.85 | 144.09 | 124.676 | 54.696 | 9.202 | 13.161 |
| Selling & Marketing Expenses
| 136.313 | 117.239 | 122.568 | 105.68 | 96.62 | 11.631 | 10.305 | 11.683 |
| SG&A
| 296.293 | 272.85 | 307.218 | 249.101 | 221.587 | 68.662 | 19.507 | 24.844 |
| Other Expenses
| -0.961 | -37.502 | -17.484 | -1.557 | -111.483 | 0 | 2.085 | -0.045 |
| Operating Expenses
| 280.297 | 295.744 | 279.664 | 222.565 | 202.73 | 0.574 | 57.097 | 52.316 |
| Operating Income
| 376.366 | 335.291 | 259.05 | 227.064 | 281.611 | 48.009 | 125.457 | 66.851 |
| Operating Income Ratio
| 0.122 | 0.122 | 0.095 | 0.094 | 0.121 | 0.116 | 0.371 | 0.23 |
| Total Other Income Expenses Net
| -37.037 | -51.502 | 8.89 | 4.892 | 15.329 | 69.613 | 2.863 | -0.791 |
| Income Before Tax
| 339.329 | 283.789 | 267.94 | 231.956 | 296.94 | 117.622 | 128.32 | 66.06 |
| Income Before Tax Ratio
| 0.11 | 0.103 | 0.098 | 0.096 | 0.127 | 0.284 | 0.379 | 0.227 |
| Income Tax Expense
| 102.203 | 88.259 | 106.19 | 77.338 | 42.121 | 18.114 | 15.724 | 8.894 |
| Net Income
| 238.163 | 209.999 | 174.541 | 158.718 | 275.001 | 103.44 | 110.735 | 56.268 |
| Net Income Ratio
| 0.077 | 0.076 | 0.064 | 0.065 | 0.118 | 0.25 | 0.327 | 0.194 |
| EPS
| 0.18 | 0.16 | 0.13 | 0.12 | 0.24 | 0.17 | 0.083 | 0.042 |
| EPS Diluted
| 0.18 | 0.16 | 0.13 | 0.12 | 0.21 | 0.17 | 0.083 | 0.042 |
| EBITDA
| 417.453 | 357.835 | 286.172 | 250.045 | 318.8 | 65.755 | 140.113 | 77.654 |
| EBITDA Ratio
| 0.135 | 0.13 | 0.105 | 0.103 | 0.137 | 0.159 | 0.414 | 0.267 |